Barry C. Johnson

746 total citations
35 papers, 531 citations indexed

About

Barry C. Johnson is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Barry C. Johnson has authored 35 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in Barry C. Johnson's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and Biochemical and Molecular Research (8 papers). Barry C. Johnson is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (9 papers) and Biochemical and Molecular Research (8 papers). Barry C. Johnson collaborates with scholars based in United States, United Kingdom and Netherlands. Barry C. Johnson's co-authors include Stephen H. Hughes, Mathieu Métifiot, Yves Pommier, Detlev Helmig, W. D. Neff, Christophe Marchand, Terrence R. Burke, F. L. Eisele, Xue Zhi Zhao and Donald R. Davis and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Barry C. Johnson

33 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry C. Johnson United States 16 211 195 182 130 100 35 531
Gemma Caballero United States 14 146 0.7× 174 0.9× 124 0.7× 144 1.1× 34 0.3× 26 781
Zhiying Liu China 13 130 0.6× 128 0.7× 79 0.4× 6 0.0× 12 0.1× 65 501
Dominique Besson France 11 83 0.4× 10 0.1× 104 0.6× 14 0.1× 24 0.2× 42 456
Donald E. Hoard United States 8 75 0.4× 17 0.1× 392 2.2× 73 0.6× 68 0.7× 15 558
Yinghua Jin China 10 140 0.7× 5 0.0× 94 0.5× 93 0.7× 151 1.5× 17 581
Stefan Weber Germany 10 33 0.2× 22 0.1× 146 0.8× 12 0.1× 8 0.1× 24 366
Weifeng Zhang China 17 29 0.1× 6 0.0× 281 1.5× 52 0.4× 29 0.3× 33 1.0k
Fabio Marino Netherlands 20 12 0.1× 11 0.1× 712 3.9× 292 2.2× 35 0.3× 37 1.5k
Susan Fotheringham United Kingdom 12 52 0.2× 3 0.0× 335 1.8× 36 0.3× 121 1.2× 25 701
Brian T. Jones United States 13 14 0.1× 4 0.0× 133 0.7× 18 0.1× 68 0.7× 19 536

Countries citing papers authored by Barry C. Johnson

Since Specialization
Citations

This map shows the geographic impact of Barry C. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry C. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry C. Johnson more than expected).

Fields of papers citing papers by Barry C. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry C. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry C. Johnson. The network helps show where Barry C. Johnson may publish in the future.

Co-authorship network of co-authors of Barry C. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Barry C. Johnson. A scholar is included among the top collaborators of Barry C. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry C. Johnson. Barry C. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Alice P., Shivaani Kummar, Larry Rubinstein, et al.. (2023). Phase 1 study of indenoisoquinoline LMP744 in adults with relapsed solid tumors and lymphomas.. Journal of Clinical Oncology. 41(16_suppl). 3022–3022. 1 indexed citations
2.
Kilpatrick, Casey L., Melinda G. Hollingshead, Dominic Esposito, et al.. (2021). Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical Biopsies. Molecular Cancer Therapeutics. 20(4). 749–760. 3 indexed citations
3.
Kummar, Shivaani, Apurva K. Srivastava, Tony Navas, et al.. (2021). Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors. Investigational New Drugs. 39(6). 1577–1586. 6 indexed citations
4.
Johnson, Barry C., et al.. (2020). Call Bell Usage: Tracking the Effect of Hourly Staff Rounding. Clinical journal of oncology nursing. 24(3). 328–330. 3 indexed citations
5.
Métifiot, Mathieu, Barry C. Johnson, Evgeny Kiselev, et al.. (2016). Selectivity for strand-transfer over 3′-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme–DNA interactions in the active site. Nucleic Acids Research. 44(14). 6896–6906. 15 indexed citations
6.
Zhao, Xue Zhi, Steven J. Smith, Mathieu Métifiot, et al.. (2014). Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants. Journal of Medicinal Chemistry. 57(4). 1573–1582. 32 indexed citations
7.
Johnson, Barry C., Mathieu Métifiot, Andrea L. Ferris, Yves Pommier, & Stephen H. Hughes. (2013). A Homology Model of HIV-1 Integrase and Analysis of Mutations Designed to Test the Model. Journal of Molecular Biology. 425(12). 2133–2146. 42 indexed citations
8.
Johnson, Barry C., Gary T. Pauly, Ganesha Rai, et al.. (2012). A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. Retrovirology. 9(1). 99–99. 31 indexed citations
9.
Zhao, Xue Zhi, Kasthuraiah Maddali, Steven J. Smith, et al.. (2012). 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(24). 7309–7313. 23 indexed citations
10.
Métifiot, Mathieu, Kasthuraiah Maddali, Barry C. Johnson, et al.. (2012). Activities, Crystal Structures, and Molecular Dynamics of Dihydro-1H-isoindole Derivatives, Inhibitors of HIV-1 Integrase. ACS Chemical Biology. 8(1). 209–217. 36 indexed citations
11.
Chung, Suhman, Jennifer T. Miller, Barry C. Johnson, Stephen H. Hughes, & Stuart F.J. Le Grice. (2011). Mutagenesis of Human Immunodeficiency Virus Reverse Transcriptase p51 Subunit Defines Residues Contributing to Vinylogous Urea Inhibition of Ribonuclease H Activity. Journal of Biological Chemistry. 287(6). 4066–4075. 21 indexed citations
12.
Johnson, Barry C., Mathieu Métifiot, Yves Pommier, & Stephen H. Hughes. (2011). Molecular Dynamics Approaches Estimate the Binding Energy of HIV-1 Integrase Inhibitors and Correlate with In Vitro Activity. Antimicrobial Agents and Chemotherapy. 56(1). 411–419. 40 indexed citations
13.
Métifiot, Mathieu, Barry C. Johnson, Steven J. Smith, et al.. (2011). MK-0536 Inhibits HIV-1 Integrases Resistant to Raltegravir. Antimicrobial Agents and Chemotherapy. 55(11). 5127–5133. 30 indexed citations
14.
Johnson, Barry C.. (2010). Algorithmic trading & DMA : an introduction to direct access trading strategies. Medical Entomology and Zoology. 29 indexed citations
15.
Johnson, Barry C., et al.. (2007). Evaluation of ozone measurements from a tethered balloon-sampling platform at South Pole Station in December 2003. Atmospheric Environment. 42(12). 2780–2787. 22 indexed citations
16.
Helmig, Detlev, et al.. (2007). Nitric oxide in the boundary-layer at South Pole during the Antarctic Tropospheric Chemistry Investigation (ANTCI). Atmospheric Environment. 42(12). 2817–2830. 32 indexed citations
17.
Johnson, Barry C., et al.. (2006). Taking the pulse of a river system: first 20 years. Fact sheet. 0–4. 3 indexed citations
18.
Johnson, Barry C.. (2006). Modelling the collision risk of London's motorcyclists. 1 indexed citations
19.
20.
Johnson, Barry C., Shannon M. Steinberg, Ruby Phelps, et al.. (1988). Female patients with small cell lung cancer live longer than male patients1. The American Journal of Medicine. 85. 194–196. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gemma Caballero Breakdown of academic impact, for papers by Zhiying Liu Breakdown of academic impact, for papers by Dominique Besson Breakdown of academic impact, for papers by Donald E. Hoard Breakdown of academic impact, for papers by Yinghua Jin Breakdown of academic impact, for papers by Stefan Weber Breakdown of academic impact, for papers by Weifeng Zhang Breakdown of academic impact, for papers by Fabio Marino Breakdown of academic impact, for papers by Susan Fotheringham Breakdown of academic impact, for papers by Brian T. Jones
Rankless by CCL
2026